Increscent Therapeutics™

In 2014, MPEG LA entered into a collaboration to develop and license therapeutic oligonucleotide conjugate technology. This led to Increscent Therapeutics™ – a versatile platform for ligand-directed multiple payload delivery of therapeutic oligonucleotides. For information on the technology and partnering/licensing opportunities:

Increscent™ Advantage
Increscent™ Overview
Increscent™ Data Package
Increscent™ Poster
Increscent™ Paper
Increscent™ News
For further information on licensing and collaborations, please contact our Biotech Group.

Upcoming Events

  • CSHL Meeting, RNA & Oligonucleotide Therapeutics, Cold Spring Harbor Laboratories, New York (March 27-30, 2019)
  • TIDES: Oligonucleotide and Peptide Therapeutics, San Diego, CA (May 21-23, 2019)
  • BIO International, Philadelphia, PA (June 3-6, 2019)
  • RNA Therapeutics: From Mechanism to Therapy, UMass Medical School, Worcester, MA (June 26-28, 2019)
  • OTS Annual Meeting, Munich, Germany (October 13-16, 2019)
  • DIA/FDA Oligonucleotide-Based Therapeutics Conference, North Bethesda, MD (October 28-30, 2019)
Scroll to Top